We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.65
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Provexis raises £50k to strengthen its capital base

Fri, 19th Feb 2021 13:19

(Sharecast News) - Heart health functional food ingredient developer Provexis has raised £50,000, it announced on Friday, to strengthen its capital base and de-risk the business further.
The AIM-traded firm said the funds were raised via a placing of 6,666,667 new shares, at a price of 0.75p each.

It noted that the placing price represented a discount of 7.4% to the closing mid-market price per share on 18 February.

"In December, the company conducted a £1m placing, and the £1.05 million funds raised from the December placing and the further placing announced today will be used to provide the company with additional working capital over the coming year to support its international growth plans," said chief executive officer Ian Ford.

"A new production run for the company's 'Fruitflow+' omega-3 dietary supplement product is in the process of being commissioned.

"The two placings conducted in December and February have significantly strengthened the company's capital base and de-risked the business, to the benefit of all shareholders."

At 1002 GMT, shares in Provexis were up 3.7% at 0.84p.
More News
3 Dec 2009 08:49

Small caps round-up: Landore Resources, TXO, Aortech...

Shares in Landore Resources jumped after the Canadian miner said it made a 'significant gold discovery' in its Junior Lake property in the province of Ontario. Shares in Texas-focused oil and gas firm TXO slumped after it said oil production in the six months to September 30 fell to 13,221 barrels

Read more
3 Nov 2009 12:16

Small cap round-up: Provexis, Puricore, Sirius, Sopheon, Spiritel

Food technology group Provexis says it has been told that the European Commission review into the health claim wording for its Fruitflow anti-thrombatic technology for use on consumer products is now in "an advanced stage". Puricore's third quarter sales rose 25% to $10.8m, with the nine month tot

Read more
11 Aug 2009 09:30

Provexis surges on Crohn's disease trial

Provexis, the life-science business, has begun a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients. "With the trial now starting and combined with recently obtained healthy human data, the Company will now commence seeking to identify potential global license or co-de

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.